Sideroblastic anemia differential diagnosis: Difference between revisions
Nazia Fuad (talk | contribs) |
Nazia Fuad (talk | contribs) |
||
Line 25: | Line 25: | ||
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
|- | |- | ||
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
Line 33: | Line 32: | ||
|- | |- | ||
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1 | ||
Line 49: | Line 46: | ||
!Iron in erythroblasts | !Iron in erythroblasts | ||
!Iron stores in bone marrow | !Iron stores in bone marrow | ||
|- | |- | ||
| | | | ||
|Sideroblastic anemia | |Sideroblastic anemia | ||
| | |Pallor | ||
| | |Weaknes | ||
| | | | ||
| | | | ||
Line 67: | Line 61: | ||
|present in ring form | |present in ring form | ||
|present | |present | ||
| | | | ||
|- | |- | ||
Line 78: | Line 67: | ||
|Iron deficiency anemia | |Iron deficiency anemia | ||
| style="background: #F5F5F5; padding: 5px;" |pallor | | style="background: #F5F5F5; padding: 5px;" |pallor | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Jaundice | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 91: | Line 80: | ||
|absent | |absent | ||
|absent | |absent | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
|Thalasemia | |Thalasemia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | [[Jaundice]] | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |jaundice | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |irritibility | ||
| style="background: #F5F5F5; padding: 5px;" |Hpatomegaly | |||
| style="background: #F5F5F5; padding: 5px;" |Splenomegaly | |||
| style="background: #F5F5F5; padding: 5px;" |Growth retardation | |||
| style="background: #F5F5F5; padding: 5px;" |micro/hypo with targeting | | style="background: #F5F5F5; padding: 5px;" |micro/hypo with targeting | ||
| style="background: #F5F5F5; padding: 5px;" |Normal -high | | style="background: #F5F5F5; padding: 5px;" |Normal -high | ||
Line 111: | Line 98: | ||
|present | |present | ||
|present | |present | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 131: | Line 113: | ||
|absent | |absent | ||
|present | |present | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 148: | Line 125: | ||
| | | | ||
| colspan="3" | | | colspan="3" | | ||
| | | | ||
| | | | ||
Line 168: | Line 140: | ||
| | | | ||
| colspan="3" | | | colspan="3" | | ||
| | | | ||
| | | | ||
Line 193: | Line 160: | ||
! | ! | ||
! | ! | ||
|'''Gold standard''' | |'''Gold standard''' | ||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tissue iron overload | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tissue iron overload | ||
Line 216: | Line 178: | ||
| | | | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 238: | Line 195: | ||
| | | | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 260: | Line 212: | ||
| | | | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|} | |} |
Revision as of 17:55, 2 August 2018
Sideroblastic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sideroblastic anemia differential diagnosis On the Web |
American Roentgen Ray Society Images of Sideroblastic anemia differential diagnosis |
Risk calculators and risk factors for Sideroblastic anemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nazia Fuad M.D.
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Differential Diagnosis
Sideroblastic anemia must be differentiated from other causes of microcytic hypochromic anemia: iron deficiency anemia, thalassemia, anemia of chronic disease, lead poisoning, and blood loss.
• Tissue iron overload from sideroblastic anemia may act similar to hereditary hemochromatosis with liver cirrhosis, diabetes, congestive heart failure, and cardiac arrhythmias.
- ALA Dehydratase Deficiency Porphyria
- Acute Myeloid Leukemia (AML)
- Congenital Erythropoietic Porphyria
- Hereditary Coproporphyria
- Iron Deficiency Anemia
- Myelodysplastic Syndrome
- Secondary Thrombocytosis
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||
Lab Findings | ||||||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Peripheral blood smear | Serum iron | Serum TIBC | Serum ferritin
g/L |
Iron in erythroblasts | Iron stores in bone marrow | |||||
Sideroblastic anemia | Pallor | Weaknes | variable | Normal -high | Normal | 50-300 | present in ring form | present | ||||||||
Microcytic hypochromic
anemia |
Iron deficiency anemia | pallor | Jaundice | microcytic/
hypochromic |
<30 | > 360 | <15 | absent | absent | |||||||
Thalasemia | jaundice | irritibility | Hpatomegaly | Splenomegaly | Growth retardation | micro/hypo with targeting | Normal -high | Normal | 50-300 | present | present | |||||
Anemia of chronic disease | Normal | Low | <300 | 30-200 | absent | present | ||||||||||
Lead poisoning | ||||||||||||||||
Blood loss | ||||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Gold standard | ||||||
Tissue iron overload | ||||||||||||||||